Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle.

Novak, James S; Hogarth, Marshall W; Boehler, Jessica F; Nearing, Marie; Vila, Maria C; Heredia, Raul; Fiorillo, Alyson A; Zhang, Aiping et al. · Nat Commun · 2018

Where this comes from

Record sourced from PubMed, PMID 29572439.
Also identified by DOI 10.1038/s41467-018-03709-8 and PMC identifier 5865121.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

The originally published version of this Article contained an error in Figure 6. In panel b, the top graph (BrdU 21-24d) and the bottom graph (BrdU 28-31d) were inadvertently swapped. This error has now been corrected in both the PDF and HTML versions of the Article.

Read the full text

View on PubMed · Publisher (DOI)